Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HMGCR | P04035 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 3/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PRKDC | P78527 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12831232 | 0.85 | ALDH1A1 (0.60) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL630196 | 0.81 | ALDH1A1 (0.51) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL31456012 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL31456106 | 0.79 | ALDH1A1 (0.53) | ALDH1A1HPGDLMNAHMGCRMAPT | |
| SCHEMBL1187473 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL16200303 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL26107991 | 0.77 | ALDH1A1 (0.50) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL7401545 | 0.77 | ALDH1A1 (0.69) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL20135982 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4ETSHRTDP1HPGD | |
| SCHEMBL31456061 | 0.77 | ERN1 (0.42) | ALDH1A1TDP1LMNAHMGCRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059373-A1 | NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |